(Q35918055)

11 August 2017

1 reference

title

Importance of patient selection when determining the significance of the CYP3A5 polymorphism in clinical trials (English)

1 reference

11 August 2017

Foti RS

1

1 reference

11 August 2017

Fisher MB

series ordinal

2

1 reference

11 August 2017

language of work or name

1 reference

1 January 2004

1 reference

The Pharmacogenomics Journal

11 August 2017

published in

1 reference

11 August 2017

volume

4

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

362-364

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500286

11 August 2017

exact match

0 references

cites work

Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500286

A significant drug-metabolizing role for CYP3A5?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500286

CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500286

Does the CYP3A5*3 polymorphism affect in vivo drug elimination?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500286

Pharmacokinetics of midazolam and 1'-hydroxymidazolam in Chinese with different CYP3A5 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500286

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500286

End-stage renal disease in African-American and white men. 16-year MRFIT findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500286

Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500286

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500286

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500286

Genotype???phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500286

Common allelic variants of cytochrome P4503A4 and their prevalence in different populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500286

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.TPJ.6500286

1 reference

Dimensions Publication ID

11 August 2017

1042975305

0 references

1 reference